Related Experiment Video
Updated: May 17, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal
Donglin Zeng1, Qingxia Chen, Ming-Hui Chen
1Department of Biostatistics, CB 7420, University of North Carolina, Chapel Hill, North Carolina 27516, U.S.A., dzeng@bios.unc.edu.
Abstract:
Treatment switching is a frequent occurrence in clinical trials, where, during the course of the trial, patients who fail on the control treatment may change to the experimental treatment. Analysing the data without accounting for switching yields highly biased and inefficient estimates of the treatment effect. In this paper, we propose a novel class of semiparametric semicompeting risks transition survival models to accommodate treatment switches. Theoretical properties of the proposed model are examined and an efficient expectation-maximization algorithm is derived for obtaining the maximum likelihood estimates. Simulation studies are conducted to demonstrate the superiority of the model compared with the intent-to-treat analysis and other methods proposed in the literature. The proposed method is applied to data from a colorectal cancer clinical trial.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Survival Analysis
Hazard Ratio
For example, in a clinical trial evaluating a...
Kaplan-Meier Approach
Assumptions of Survival Analysis

